close
MENU
Hot Topic NBR Focus: GMO
Hot Topic NBR Focus: GMO
0 mins to read

Fonterra buys Indian pharmaceutical company


Fonterra has bought an Indian pharmaceutical company as part of a joint venture with Dutch company Royal FrieslandCampina.

Nicola Williams
Wed, 31 Aug 2011

Fonterra has bought an Indian pharmaceutical company as part of a joint venture with Dutch company Royal FrieslandCampina.

It will extend Fonterra’s dominance as the leading supplier of lactose excipients.

DMV-Fonterra Excipients (DFE) has reached an agreement to acquire ingredient manufacturer Brahmar Cellulose Private Limited (BCPL), based in Cuddalore, India.

BCPL manufactures ingredients used by the pharmaceutical industry to make tablets and pills.

DFE accounts for about 50% of global sales of lactose excipients and 5 to 10% of oral tablet excipients.

The acquisition will help reduce supply chain and formulation costs, Fonterra said.

Nicola Williams
Wed, 31 Aug 2011
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Fonterra buys Indian pharmaceutical company
16673
false